Two Sigma Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $18.6M | Sell |
|
|||||
|
2024
Q2 | $89.8M | Buy |
|
|||||
|
2024
Q1 | $57.5M | Buy |
|
|||||
|
2023
Q4 | $24.2M | Sell |
|
|||||
|
2023
Q3 | $24.6M | Buy |
|
|||||
|
2023
Q2 | $2.53M | Sell |
|
|||||
|
2023
Q1 | $133M | Buy |
|
|||||
|
2022
Q4 | $79.1M | Sell |
|
|||||
|
2022
Q3 | $105M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $18.1M | Sell |
|
|||||
|
2021
Q4 | $59.5M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $12M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $9.18M | Sell |
|
|||||
|
2020
Q1 | $35.4M | Sell |
|
|||||
|
2019
Q4 | $80.8M | Buy |
|
|||||
|
2019
Q3 | $39.8M | Sell |
|
|||||
|
2019
Q2 | $91.5M | Buy |
|
|||||
|
2019
Q1 | $27.1M | Buy |
|
|||||
|
2018
Q4 | $230K | Buy |
|